Ceapro Inc. (CVE:CZO – Get Free Report)’s share price dropped 11.8% on Tuesday. The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares changed hands during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Trading Down 11.8%
The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54. The business’s 50 day moving average price is C$0.22 and its 200-day moving average price is C$0.23. The firm has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Further Reading
- Five stocks we like better than Ceapro
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}